Back to Trials
NCT01094327Recruiting

Proteinuria in Pre and Post Transplant

University of Miami

Start Date

2/1/2008

Completion Date

11/30/2026

Summary

Patients with focal segmental glomerulosclerosis (FSGS) who progress rapidly to end stage renal disease (ESRD) are at highest risk for development of recurrence of proteinuria following kidney transplantation. This study will look at serum specimens pre and post transplant, as well as kidney transplant specimens pre and post reperfusion to identify where the defects has occured that results in recurrence of proteinuria in a given kidney transplant.

Detailed Description

This study will retrospectively review patient's medical records for protein in the urine, blood creatinine and kidney biopsy results. Also character of the fluid used to flush the kidney before transplant will be analyzed.

Eligibility Criteria

Age Range: No minimum to 25 years

Inclusion Criteria: * Kidney transplant recipients * Pediatric males and females up to the age of 25 years old. Exclusion Criteria: * Transplant recipients other than kidney

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Proteinuria

Locations

University of Miami Miller School of Medicine Transplant Clinic

Miami, Florida 33136

United States